Yumiko Tsushima, MD
- Assistant Professor, CWRU School of Medicine
- Specialty: Endocrinology
-
Location:UH Cleveland Medical Center Mather
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3142
Biography: Yumiko Tsushima, MD
Certifications & Memberships
- Endocrinology, Diabetes and Metabolism - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Endocrinology
Endocrinology - Cleveland Clinic (2019 - 2021)
Residency | Internal Medicine
Internal Medicine - Mount Sinai Beth Israel (2016 - 2019)
Medical Education
Shiga University Of Medical Science (2013)
Undergraduate
Cornell University (2008)
About
Yumiko Tsushima, MD, is an endocrinologist at University Hospitals. She is a graduate of Cornell University, where she received her bachelor's degree and earned her medical degree from Shiga University of Medical Science in Japan. She completed her residency at Mount Sinai Beth Israel Medical Center and her endocrinology fellowship at the Cleveland Clinic Foundation in 2021 prior to joining University Hospitals. She is an Assistant Professor of Medicine at Case Western Reserve University.
Dr. Tsushima is a member of a number of professional societies, including the American Association of Clinical Endocrinology and the American Diabetes Association. Dr. Tsushima has presented at numerous national meetings and published her work on a wide spectrum of endocrinology disorders. Her primary research interest involves diabetes treatment and identifying risks associated with diabetes.
She has been featured and published in several national and local presentations covering endocrinology studies and reports. She has also produced endocrinology teaching material for trainees and staff.
Research & Publications
Research Interests
diabetes treatment, risks associated with diabetes
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Yumiko Tsushima did not disclose any Outside Relationships with Industry.